FDA MedWatch: Welch Allyn AED 10 Automatic External Defibrillators
FDA MedWatch: Welch Allyn AED 10 Automatic External Defibrillators manufactured between 3/29/07 and 8/9/07 – Class 1 Recall MedWatch – The FDA Safety Information and Adverse Event Reporting Program FDA issued a Class I recall for Welch Allyn AED 10 Automatic External Defibrillators manufactured between March 29, 2007 and August 9, 2007, part numbers 970302E, […]
Subject: FDA- MedWatch- Aprotinin Injection (marketed as Trasylol)
Subject: FDA- MedWatch- Aprotinin Injection (marketed as Trasylol)- Patient Enrollment In The Aprotinin Treatment Group Arm of BART Study Stopped MedWatch – The FDA Safety Information and Adverse Event Reporting Program FDA informed healthcare professionals of the Data Safety Monitoring Board's recommendation to stop patient enrollment in the aprotinin treatment group arm of the Blood […]
FDA MedWatch: Trasylol (aprotinin injection)
FDA MedWatch: Trasylol (aprotinin injection) – FDA requests marketing suspension and Bayer Pharmaceutical Corp. has agreed, pending a detailed review of preliminary results from a Canadian study that suggested an increased risk for death MedWatch – The FDA Safety Information and Adverse Event Reporting Program FDA announced that, at the agency's request, Bayer Pharmaceuticals Corp. […]
Alternative Treatments for Wounds: Leeches, Maggots, and Bees
Karen M. Dente, MA, MDIntroduction The recalcitrant nature and complexity of chronic wounds continue to challenge health practitioners in the field, with many of the standard treatment options often failing to provide good outcomes. Chronic wounds are often infected with bacteria resistant to antibiotics, compounding the problem. Some alternative biologic forms of treatment have been […]
Updated Warfarin (Coumadin) labeling includes new genetic information
FDA – MedWatch – Updated Warfarin (Coumadin) labeling includes new genetic information that may help providers improve initial dosing estimates of anticoagulant for individual patients
Baxter Healthcare Corp. Recalls Baxter COLLEAGUE And FLO-GARD
FDA – MedWatch – Baxter Healthcare Corp. Recalls Baxter COLLEAGUE And FLO-GARD Volumetric Infusion Pumps Because Of Falsification Of Service And Repair Data
Baxter Healthcare Corp. and FDA notified healthcare professionals
FDA – MedWatch – Baxter Healthcare Corp. and FDA notified healthcare professionals and consumers of a Class I Recall of Baxter Upgraded COLLEAGUE Triple Channel Volumetric Infusion Pumps, Model numbers 2M8153, 2M8163, and 2M9163.
Merck Recalls 3 Lots Of Invanz
FDA – MedWatch – Merck Recalls 3 Lots Of Invanz (ertapenem sodium) Injection Because The Product May Contain Broken Glass Pieces In The Reconstituted Solution For Injection
FDA Clears First Filtering Respirator for Public Use in Emergency
FDA has cleared for marketing the first respirators to be used by the public during public health emergencies, such as an influenza pandemic. Called the 3M Respirator 8612F and 8670F, these products will be available without a prescription.
International Health Regulations enter into force
New opportunity to respond to international public health threats 14 JUNE 2007 | GENEVA — The revised International Health Regulations (IHR) enter into force on Friday, 15 June. The Regulations consist of a comprehensive and tested set of rules and procedures which will help to make the world more secure from threats to global health. […]
